title: [Immunorehabilitation in patients with paecilomycosis-complicated echinococcosis and asthma].
abstract: Paecilomycosis is a new type of systemic mycosis caused by different species of fungi of the genus Paecilomyces. Paecilomycosis-complicated echinococcosis and asthma run a severe course. A complication of mycosis is accompanied by secondary immunodeficiency. A good result was obtained in the treatment of ill children by using the fungicide diflucan and the immunomodulator polyoxidonium. In the examinees with paecilomycosis-complicated echinococcosis, secondary immunodeficiency was characterized by a statistical significant reduction in the blood levels of the lymphoid cells CD3+, CD4+, CD8+, CD16+, CD21+, by phagocytosis, a decrease in its quantitative parameters, and an increase in the counts of immunoglobulins and circulating immunocomplexes. To normalize the immune status in patients with paecilomycosis-complicated echinococcosis, it is expedient to postsurgicallyuse fungicides, such as nizoral, diflucan, orungal, mycosyst, and the immunomodulators polyoxidonium and irillen.
authors.forename: A V
authors.initials: AV
authors.lastname: Streliaeva
authors.forename: V V
authors.initials: VV
authors.lastname: Polzikov
authors.forename: T A
authors.initials: TA
authors.lastname: Shcheglova
authors.forename: É R
authors.initials: ÉR
authors.lastname: Gasparian
authors.forename: E S
authors.initials: ES
authors.lastname: Prokina
authors.forename: R V
authors.initials: RV
authors.lastname: Sadykov
authors.forename: N B
authors.initials: NB
authors.lastname: Lazareva
authors.forename: I A
authors.initials: IA
authors.lastname: Samylina
authors.forename: V M
authors.initials: VM
authors.lastname: Sadykov
authors.forename: N V
authors.initials: NV
authors.lastname: Chebyshev
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D001249:Asthma / Q000276:immunology* / Q000382:microbiology / Q000503:physiopathology; D004443:Echinococcosis / Q000188:drug therapy / Q000276:immunology* / Q000382:microbiology / Q000503:physiopathology; D015725:Fluconazole / Q000008:administration & dosage; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D017964:Itraconazole / Q000008:administration & dosage; D007654:Ketoconazole / Q000008:administration & dosage; D009181:Mycoses / Q000276:immunology* / Q000503:physiopathology; D010143:Paecilomyces / Q000276:immunology; D010879:Piperazines / Q000008:administration & dosage; D011108:Polymers / Q000008:administration & dosage
chemical_list: D000935:Antifungal Agents; D007155:Immunologic Factors; D010879:Piperazines; D011108:Polymers; D017964:Itraconazole; D015725:Fluconazole; C540909:azoximer bromide; D007654:Ketoconazole